BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9223096)

  • 1. Expression of schwannomin in lens and Schwann cells.
    Claudio JO; Veneziale RW; Menko AS; Rouleau GA
    Neuroreport; 1997 May; 8(8):2025-30. PubMed ID: 9223096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
    Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
    Huynh DP; Pulst SM
    Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
    Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF
    Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B; Ballhausen WG; Kressel M
    Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 gene.
    Claudio JO; Lutchman M; Rouleau GA
    Neuroreport; 1995 Oct; 6(14):1942-6. PubMed ID: 8547603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schwannomin: new insights into this member of the band 4.1 superfamily.
    Belliveau MJ; Lutchman M; Claudio JO; Marineau C; Rouleau GA
    Biochem Cell Biol; 1995; 73(9-10):733-7. PubMed ID: 8714694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
    Sainio M; Zhao F; Heiska L; Turunen O; den Bakker M; Zwarthoff E; Lutchman M; Rouleau GA; Jääskeläinen J; Vaheri A; Carpén O
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2249-60. PubMed ID: 9378774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal absence of merlin, but not other ERM family members, in schwannomas.
    Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
    Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas.
    Gutmann DH; Giordano MJ; Fishback AS; Guha A
    Neurology; 1997 Jul; 49(1):267-70. PubMed ID: 9222206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding.
    Thaxton C; Lopera J; Bott M; Baldwin ME; Kalidas P; Fernandez-Valle C
    Mol Cell Neurosci; 2007 Feb; 34(2):231-42. PubMed ID: 17175165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.
    Goutebroze L; Brault E; Muchardt C; Camonis J; Thomas G
    Mol Cell Biol; 2000 Mar; 20(5):1699-712. PubMed ID: 10669747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor schwannomin/merlin is critical for the organization of Schwann cell contacts in peripheral nerves.
    Denisenko N; Cifuentes-Diaz C; Irinopoulou T; Carnaud M; Benoit E; Niwa-Kawakita M; Chareyre F; Giovannini M; Girault JA; Goutebroze L
    J Neurosci; 2008 Oct; 28(42):10472-81. PubMed ID: 18923024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells.
    Scherer SS; Gutmann DH
    J Neurosci Res; 1996 Dec; 46(5):595-605. PubMed ID: 8951671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of schwannomin/merlin in human sporadic meningiomas.
    Lee JH; Sundaram V; Stein DJ; Kinney SE; Stacey DW; Golubić M
    Neurosurgery; 1997 Mar; 40(3):578-87. PubMed ID: 9055299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas.
    Kimura Y; Koga H; Araki N; Mugita N; Fujita N; Takeshima H; Nishi T; Yamashima T; Saido TC; Yamasaki T; Moritake K; Saya H; Nakao M
    Nat Med; 1998 Aug; 4(8):915-22. PubMed ID: 9701243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.